Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Neuromodulation Systems Settles Kickback Allegations

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical subsidiary Advanced Neuromodulation Systems reached a $2.95 million settlement with the federal government July 2 and agreed to strict internal oversight of its sales and marketing practices for the next three years to resolve allegations of physician kickbacks

You may also be interested in...



When Corporate Integrity Agreements Multiply, Firms Know What To Expect

Orthopedic companies will likely be among the next device firms subject to corporate integrity agreements with the HHS Office of Inspector General, and stakeholders say there are clues as to what they should expect

Medtronic To Track Sales Contacts, Pay $40 Mil. To Settle Kickback Probe

Medtronic will begin recording all transactions between its spine product sales personnel and physicians as part of a settlement agreement with the U.S. Department of Justice

State Drug Advertising Laws Foreshadow Future Device Regulation

Device manufacturers should begin tracking gifts given to physicians in anticipation of increased state regulation of marketing and promotional activities, according to Kyphon Chief Compliance Officer Bert Johnson

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024983

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel